UBS Maintains Neutral on Corteva, Raises Price Target to $89

Corteva Inc

Corteva Inc

CTVA

0.00

UBS analyst Joshua Spector maintains Corteva (NYSE: CTVA) with a Neutral and raises the price target from $86 to $89.